ETF model portfolios designed for real investor needs. Discover →
ARK Genomic Revolution ETF
ARKG performance and flow charts
Performance
Flows
Historic performance and flows
Data as of April 27, 2026| 1M | 3M | YTD | 1Y | 3Y | 5Y | |
|---|---|---|---|---|---|---|
| Perf. | +19.74% | -7.79% | +2.44% | +33.74% | +3.79% | -67.31% |
| Flows | -$22M | -$94M | -$37M | -$81M | -$609M | -$3.04B |
Characteristics
This fund is actively managed; it does not track an index. This share class generates a stream of income by distributing dividends.
| Management strategy | Active |
| Strategy | Long Only |
| Provider | Ark Investment |
| N° of holdings | 27 |
| Dividend policy | Distributing |
Trailing 12m distribution yield | Join for free |
| Inception date | April 2, 2019 |
| ESG | No |
More data and info about ARKG on Trackinsight
Exposure
Data as of March 31, 2026Diversification
Total weight of top 15 holdings out of 27
Top 15 Holdings
Sectors
Countries
Latest news about ARKG
Similar ETFs
Trading data
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Volatility | +42.80% | +41.55% | +42.57% | +45.35% |
Max drawdown | -23.56% | -27.52% | -51.98% | -80.16% |
Max drawdown duration | 90d | 95d | 1013d | 1763d |
Time to recover | N/A | N/A | N/A | N/A |
What type of ETF is ARKG?
ARKG is a Active ETF that provides exposure to Equity assets. It is managed by Ark Investment.
What does ARKG invest in?
This ETF provides exposure to Other Equities. It is part of the segment: BioTech & Genomics.
What is the expense ratio of ARKG?
The total expense ratio (TER) of ARKG is 0.75%, representing the annual fee charged by the fund manager.
When was ARKG launched?
ARKG was launched on April 2, 2019, marking its entry into the ETF market.
Who is the issuer of ARKG?
ARKG is issued by Ark Investment.
What is the AUM of ARKG?
As of April 27, 2026, ARKG manages $1.16 B, reflecting the total assets held in the fund.
How has ARKG performed recently?
As of April 27, 2026, ARKG delivered a return of 19.74% over the past month (1M performance), -7.79% over the past three months (3M), and 2.44% year-to-date (YTD).
What are the recent fund flows for ARKG?
As of April 27, 2026, ARKG has seen net flows of -$22M in the past month (1M flow) and -$37M year-to-date (YTD).
How many holdings are in ARKG
As of March 31, 2026, ARKG holds 27 securities in its portfolio. This level of diversification can influence the fund’s risk profile and exposure to individual assets.
How diversified is ARKG?
As of March 31, 2026, ARKG holds 27 securities, with 62.5% of its assets concentrated in its top 15 holdings.
What are the top holdings of ARKG?
As of March 31, 2026, ARKG holds a portfolio of 27 underlyings, with its largest positions including CRISPR THERAPEUTICS, 10X GENOMICS INC and BEAM THERAPEUTICS. These top holdings play a significant role in shaping the fund’s performance and exposure.
What countries or regions does ARKG invest in?
As of March 31, 2026, ARKG has its largest geographic exposures in USA and Switzerland.
What sectors or themes does ARKG focus on?
As of March 31, 2026, ARKG is primarily exposed to Health Care.
Advantages of ETFs over Mutual Funds1/6
Lower Costs
In this guide, we'll explore the advantages of ETFs over mutual funds, giving you valuable insights into why ETFs have gained significant popularity among investors like yourself.
Leveraged ETFs: Unlocking the Potential for Amplified Returns1/6
Understanding Leveraged ETFs
Explore leveraged ETFs: potential for amplified returns & risks. 5 ETFs to consider across equities, commodities & fixed income.
What is a Leveraged ETF?1/6
Introducing Leveraged and Inverse ETFs
In this guide, we'll dive into the world of leveraged ETFs, exploring their definition, mechanics, potential risks, and rewards.
Recent educational content
What’sTheFund
What's the Fund | State Street SPDR IG Public & Private Credit ETF (Ticker: PRIV)
Matthew Bartolini, Global Head of Research Strategists, at State Street Investment Management, joins Ethan Hertzfeld on the New York Stock Exchange Floor to discuss PRIV, the State Street SPDR IG Public & Private Credit ETF.
ETF Trends
ETF Industry KPIs April 27, 2026
The ETF Industry saw 23 New Launches, 1 Ticker Change and 4 closures last week.
Asset TV
The ETF Show - Investors Can Fight Healthcare Inflation with Newly Launched ETFs
Adam Schenck, Principal and Managing Director of Fund Services at Milliman joined The ETF Show to discuss Milliman's first ETFs designed to hedge against rising healthcare inflation.
ETF Trends
ETF Industry KPIs April 20, 2026
The ETF Industry saw 14 New Launches, 1 Ticker Change and 16 closures last week.
Browse all educational columns
Calamos Investments Powers the Next Phase of the Autocallable Revolution
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
